mRNA LNP Formulation
With our specialized sites around the world including the U.S. and E.U., Curia is your drug substance through drug product partner. Local to you, we use phase-appropriate services to support your first-to-clinical goals.
Drug product LNP formulation development and manufacturing
- Analytical and formulation development
- Process development and optimization
- Technology transfer and aseptic fill-finish for liquid and lyophilized drug products
- Expertise and equipment to support multiple LNP methodologies (solvent injection, microfluidics, etc.) and associated analytics
- Scalable aseptic manufacturing for pre-clinical through Phase III clinical trials
- Automated aseptic fill finish for liquid and lyophilized
- Fully disposable product contact parts
- LNP equipment to support development through cGMP
- On-site analytics for in-process, lot release, and stability testing